These findings, together with the strong correlation between CD38 positivity and PD1 positivity on CD8+ T cells found in our study, suggests that CD38 is likely an important player in the regulation of T cell suppression in lung cancer patients. This evidence concerns the gene CD38 and lung carcinoma.